WEST PHARMACEUTICAL SERVICES, INC. Other Comprehensive Income (Loss), Reclassification Adjustment on Derivatives Included in Net Income, Net of Tax (Deprecated 2012-01-31)
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Other Comprehensive Income (Loss), Reclassification Adjustment on Derivatives Included in Net Income, Net of Tax (Deprecated 2012-01-31) of $700.00 thousand for the 3-month period ending 2011-09-30, per its 10-Q filed 2011-11-07.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax · last filed 2011-11-07
- WEST PHARMACEUTICAL SERVICES, INC. other comprehensive income (loss), reclassification adjustment on derivatives included in net income, net of tax (deprecated 2012-01-31) for the quarter ending 2011-09-30 was $700.00K, a 40.00% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. other comprehensive income (loss), reclassification adjustment on derivatives included in net income, net of tax (deprecated 2012-01-31) for the quarter ending 2011-06-30 was $600.00K, a 25.00% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. other comprehensive income (loss), reclassification adjustment on derivatives included in net income, net of tax (deprecated 2012-01-31) for the quarter ending 2010-09-30 was $500.00K.
- WEST PHARMACEUTICAL SERVICES, INC. other comprehensive income (loss), reclassification adjustment on derivatives included in net income, net of tax (deprecated 2012-01-31) for the quarter ending 2010-06-30 was $800.00K.
| Period end | Other Comprehensive Income (Loss), Reclassification Adjustment on Derivatives Included in Net Income, Net of Tax (Deprecated 2012-01-31) 3 month | Other Comprehensive Income (Loss), Reclassification Adjustment on Derivatives Included in Net Income, Net of Tax (Deprecated 2012-01-31) 6 month | Other Comprehensive Income (Loss), Reclassification Adjustment on Derivatives Included in Net Income, Net of Tax (Deprecated 2012-01-31) 9 month |
|---|---|---|---|
| 2011-09-30 | $700.00K 10-Q · filed 2011-11-07 | $1.30M derived: sum of 2 quarters · filed 2011-11-07 | $2.10M 10-Q · filed 2011-11-07 |
| 2011-06-30 | $600.00K 10-Q/A · filed 2011-08-08 | $1.40M 10-Q/A · filed 2011-08-08 | |
| 2010-09-30 | $500.00K 10-Q · filed 2011-11-07 | $1.30M derived: sum of 2 quarters · filed 2011-11-07 | $2.10M 10-Q · filed 2011-11-07 |
| 2010-06-30 | $800.00K 10-Q/A · filed 2011-08-08 | $1.60M 10-Q/A · filed 2011-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |